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Research article
Ερευνητικό άρθρο
ABSTRACT: The study was designed to determine the blood levels of omega fatty acids, which have an important 
role in the etiology of mammary tumours, in healthy and female dogs with mammary tumour. The study was carried out 
in 9 female dogs with histologically confirmed mammary tumour and a control group with 9 healthy female dogs with-
out clinical mammary neoplasia. 10 ml cephalic blood samples were collected by using a 21G x 1.5΄΄ blood collecting 
needle into anticoagulated tubes before the surgical removing of the mammary masses. Mastectomy was performed in 
all female dogs with mammary tumours and all the mammary specimens were sent to laboratory for histopathological 
examination. According to histopathological diagnosis results, all of the tumours were found to be malignant. Omega-3 
levels were found to be higher in healthy female dogs (p<0.001) whereas omega-6 levels were higher in female dogs 
with mammary tumour (p<0.001). These observations support the notion tha thigh levels of omega-3 fatty acids might 
proove to have a protective role on mammary tumor formation in female dogs, while increased levels of omega-6 fatty 
acids may be related to an increased mammary tumor risk. This difference between omega-3 and omega-6 levels was 
found to be caused mainly by Eicosatrienoic acid. It is concluded that omega fatty acids mayplay an important role in 
the biological mechanism of mammary tumour in female dogs.
Keywords: female dog, mammary tumour, omega-3, omega-6.
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INTRODUCTION
Mammary tumours are important for canine health as they are encountered very commonly 
in female dogs. Reports indicate that among all mam-
malian species, female dogs present with the highest 
incidence of mammary tumours. Compared to other 
reproductive organs, the mammary glands are five 
times more prone to the development of tumours. 
Mammary tumours can be localized to a single gland 
or can be observed simultaneously in all mammary 
glands. In female dogs, approximately 40% of all 
mammary tumours occur in the inguinal mammary 
glands, and 60% occur in the thoracic and abdominal 
glands. Nearly 50% of all mammary tumours are of 
malignant character. Definitive diagnosis is based on 
the histopathological examination of an incisional or 
excisional biopsy (Bostock, 1986; Reddy et al., 2009).
Diet is suggested to have a major role in etiology 
of mammary neoplasia (MacLennan and Ma, 2010). 
Essential fatty acids (EFAs) are polyunsaturated fatty 
acids (PUFAs), which are not synthesized in the body, 
and therefore need to be ingested with food. Essential 
fatty acids are classified under two groups, namely, 
omega-3 (ω-3) fatty acids and omega-6 (ω-6) fatty 
acids (Gültiken and Vural, 2004; Zatsick and Mayket, 
2007). The principal ω-3 fatty acids include linolenic 
acid (LNA), eicosapentaenoicacid (EPA), docosahex-
aenoicacid (DHA) andstearidonic acid (SDA) (Geb-
auer et al., 2005). Omega-3 fatty acids are found in 
vegetable oils (linseed oil, walnut oil), seeds, green-
leafy vegetables, beans and nuts, and fatty fish. Fur-
thermore, the principal ω-6 fatty acids include linoleic 
acid (LA), arachidonic acid (AA) and gamma-linoleic 
acid (GLA).Omega-6 fatty acids are found in maize 
oil, sunflower seed oil, soybean oil, cottonseed oil,saf-
flower oil, peanut oil, and margarine, as well as in the 
liver, brain, and red meat and poultry meat (Lasekan 
and Ney, 1990; Greenly, 2002). 
Essential fatty acids may contribute to formation 
of mammary neoplasia (MacLennan and Ma, 2010). 
In the extensive meta-analyze study of Fay et al. 
(1997), it was shown that ω-6 fatty acids promoted 
the tumour development substantially in the rodents. 
Rose et al. (1995) reported that diets containing lin-
oleic acid supplemented with eicosapentaenoic acid 
or docosahexaenoic acid led to lesser tumour growth 
and lung metastasis compared to the diets with only 
linoleic acid in the athymic nude mice. In an in vitro 
study, arachidonic acid, a member of the ω-6 fatty 
acids, was shown to increase the proliferation of en-
dothelial cells derived from human breast carcinomas 
and trigger formation of vessel-like structures(Pla et 
al., 2008). On the contrary, in the prepubertal rats, 
exposure to low-fat ω-3 PUFA diet caused reduction 
in the mammary tumorigenesis (Olivo and Hilakivi-
Clarke, 2005). Exogenous supplementation of ω-3 fat-
ty acid docosahexaenoic acid (DHA) in human breast 
cancer cells downregulates Her-2/neu expression and 
decrease tumour growth rate (Menendez et al., 2005).
Sonnenschein et al. (1991) showed that high-fat diet 
had protective effects on the mammary tumour risk in 
dogs. But this study didn’t have any detailed informa-
tion on which type of fatty acid are present in the diet 
due to the scarce data about dog food preparations.
Obesity or overweight might be associated with more 
aggressive tumours (Costa-Santos et al., 2019). This 
relationship between obesity/overweight is resulting 
from the activation of insulin/IGF-1 pathway, high 
level of pro-inflammatory cytokines (TNF-α, IL-1 and 
IL-6) and their influence on adipocytokines (Lim et al., 
2015). The level of plasma insulin-like growth factor-I 
(IGF-I), known to have a regulatory role in tumour de-
velopment, has been reported to decrease in mammary 
tissue with an increase in the ratio of omega-3 fatty 
acids to omega-6 fatty acids (Zhu et al., 2011).
Supplementation for long period than three 
months with fish oil, rich in omega-3 fatty acids, 
can control dyslipidemia in dogs. It is expressed that 
dyslipidemias are possible factors related with ac-
celerated tumor genesis (Costa-Santos et al., 2019). 
Major changes occured in our diet since the Agricul-
tural Revolution began 10.000 years ago (Simopou-
los, 1999). Especially, type and amount of essential 
fatty acids in the diets changed dramatically (Eaton 
and Konner, 1985). In today’s industrialized societies, 
diets include more ω-6 fatty acids and less ω-3 fatty 
acids (Eaton and Konner, 1985; Simopoulos, 1999).
Due to the increased production of industrial food and 
the altered nutrient composition of animal feedstuffs, 
various food such as red meat, fish and poultry meat 
have become significantly poorer in ω-3. Therefore, 
the dietary intake of ω-3 fatty acids has fallen below 
that of ω-6 fatty acids (Candela et al., 2011).
It is indicated that food rich in ω-6 triggers the pro-
duction and release of oestrogen, the increased lev-
els of which are known to induce tumour growth, in 
adipose tissue in human (Nagata et al., 2007).There-
fore, it is suggested that reducing the dietary intake of 
ω-6 fatty acids could decrease the prolactin-binding 
capacity of tumours and thereby, slow down tumour 
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growth in rats (Cave and Erickson-Lucas, 1982).In-
creasing the ratio of omega-3 fatty acids toω-6 fatty 
acids in the diet is considered an important tool in re-
ducing the risk of mammary tumours and preventing 
their post-excision recurrence (Rose, 1997).
The ω-6 fatty acid most used by tumour cells is 
reported as AA (MacLennan and Ma, 2010). Linoleic 
acid, which is an ω-6 fatty acid, is converted to AA, 
a precursor of eicosanoids, when metabolized in the 
body. A high level of dietary intake of ω-6 fatty acids 
increases the level of AA in the body, and thereby, 
increases the production of pro-inflammatory eicosa-
noids such as prostaglandins, which are synthesized 
from AA (Gebauer et al., 2005). Malignant tumour 
cells are reported to synthesize a higher level of eico-
sanoids than benign tumour cells, and eicosanoids are 
known to be capable of accelerating tumour growth. 
As eicosanoids synthesized in the body are produced 
from EFAs, the eicosanoid level of the tumour and 
host are both affected by the type and level of EFAs in 
the diet (Cave, 1996).
The EFA least used by mammary tumour cells is 
EPA, anω-3 fatty acid, which is used in the treatment 
of certain types of cancers (Ward and Singh, 2005). 
In the body, by means of various desaturase isoforms, 
LA is converted to AA, and LNA is first converted to 
EPA and then to DHA. As ω-3 fatty acids and ω-6 fat-
ty acids compete for desaturase enzymes, an increased 
consumption of LNA, EPA and DHA decreases the 
production ofAA (Cowing and Saker, 2001). The two 
main compounds required for eicosanoid synthesis 
are AA and EPA. Eicosanoids synthesized from AA 
(AA-derived eicosanoids) have properties opposite 
to those of EPA-derived eicosanoids. As AA and EPA 
compete for cyclooxygenases (COX) and lipoxygen-
ases (LOX), they lead to the synthesis of eicosanoids 
with opposing properties. Generally, while AA-de-
rived eicosanoids show a pro-inflammatory effect,E-
PA-derived eicosanoids have an anti-inflammatory 
effect (Cowing and Saker, 2001).
The study was designed to determine the blood 
levels of omega fatty acids, which may play an im-
portant role as modifiers of breast cancer risk, in 




The study material comprised 18 female dogs of 
various breeds. Study group was created with Ger-
man Shepherd (n:4), Terrier (n:3), Setter (n:2); and 
control group was composed by German Shepherd 
(n: 2), Terrier (n:3), Beagle (n:1), mix (n:3) breed. 
Nine of which were admitted to the veterinary clinic 
with signs of a mass structure (lump) in the mammary 
gland and were clinically diagnosed with mammary 
tumour, and the other 9 of which were healthy female 
dogs. Of the female dogs diagnosed with mammary 
tumour, four were eight years old, one was nine years 
old, and the remaining four were aged 10 years or 
older. The healthy female dogs were selected among 
animals older than 5 years of age. Reproductive his-
tory of the female dogs with mammary tumours and 
healthy female dogs include status of ovariohyster-
ectomy, age at first estrus, number of full-term preg-
nancy, age at first pregnancy, hormonal treatment to 
prevent or inhibit estrus. Female dogs diagnosed with 
mammary tumors, 7 were not neutered and 2 were 
neutred previously and these animals had been neu-
tered after the age of five. All healthy dogs for control 
group were selected from neutered and these animals 
had been neutered before the age of three. Any ani-
mals were not treated with the hormones to prevent 
or inhibit the estrus. All of the dogs are owned by the 
second owners. Therefore, no definite information 
about when the first estrus took place. None of the 
dogs in control group gave a birth except from one 
which had a dystocia in its first parturition. Only this 
dog had an ovariohysterectomy operation as an surgi-
cal treatment of dystocia. Of female dogs with mam-
mary tumours, only two of them gave birth. The rest 
of them didn’t have pregnancy. All animals were fed 
with homemade and dry commercial diet. Amount of 
commercial diet fed to the dogs are based on brand 
recommendation. Homemade meals are not main part 
of diet, generally given to the dogs as a reward per 
day. Body condition score (BCS) was performed ac-
cording to nine-point BCS system (Laflamme, 1997). 
All animals were in the normal body weight (4-5/9).
Mammary tumors were found in inguinal mamma-
ry glands in 5 female dogs in which 3 female dogs had 
tumor on only one mammary gland while 2 female 
dogs had tumors on two mammary glands. Axillar 
mammary gland tumors were detected in 3 female 
dogs in which 2 female dogs had tumors on only one 
mammary gland while one female dog had tumors 
on two mammary glands. In one female dog multiple 
masses detected, one tumoral mass on axillary gland 
and two masses on inguinal gland. 
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Methods
Informed client consent was taken before the clin-
ical examination of the dogs. Prior to clinical exam-
ination, the medical history including the location of 
the mammary masses, history of ovariohysterectomy, 
housing and general nutrition conditions of the female 
dogs was recorded on an inspection form. Ten-ml 
whole blood samples were collected by cephalic ve-
nepuncture by using 21G x 1.5΄΄ blood collecting nee-
dle from both the animals diagnosed with mamma-
ry tumour, prior to surgery, and the healthy animals, 
into anticoagulated tubes, and were stored during two 
months at -20 ○C until being analyzed for fatty acids. 
The masses suspected of being mammary tumours 
were excised by mastectomy, and were transferred to 
the laboratory for histopathological examination after 
fixed with formalin. Any biopsy procedure was not 
performed before surgery to the tumoral mass.
Following atropine sulphate(Atropin 0.2%, Vetaş, 
Turkey)(0.45 mg/kg, sc) application for preanesthet-
ic,general anesthesia was performed by xylazine hy-
drochloride (Basilazin %2, Bavet, Turkey) (2 mg/kg, 
im) and ketamine hydrochloride (Ketasol 10%, Rich-
ter Pharma AG, Austria)(10 mg/kg, im) combination. 
After general anesthesia routine surgical procedure 
was applied. Female dogs which had multiple masses 
on mammary gland were undergone unilateral total 
mastectomy (all tumor masses, mammary glands, in-
guinal and axillary lymph nodes were removed).Fe-
male dogs which had even single or more masses on 
inguinal or axillary gland were undergone unilateral 
partial mastectomy (primer tumoral mass, connected 
mammary glands and lymph nodes were removed).
Histopathological Method
The mammary masses, belonging to the 9 animals 
suspected of having mammary tumours, were firstly 
fixed in 10% formalin solution. The tissue samples 
were processed in an automated processor (Leica 
TP 1020), such that they were dehydrated through 
alcohol and xylolseries, embedded in paraffin and 
hardened on a cryoconsole (Hestion TEC 2800 Em-
bedding Center), and sliced into5-μm-thick sections 
using a Leica RM 2135 rotary microtome. The sec-
tions were deparaffinised in xylol, passed through a 
series of graded alcohols (100%, 96%, 80%,70%), 
and stained with haematoxylin-eosin (H&E) (Luna, 
1968). The sections were examined under a light mi-
croscope (Olympus BX35), and were photographed 
with a digital camera (Olympus SC 180).Tumour 
classification was based on the criteria described by 
Michael et al. (2017).
Fatty Acid Analysis
Ten-ml blood samples taken from all of the ani-
mals into anticoagulated tubes containing sodium 
EDTA were transferred to the laboratory under cold 
chain. The tubes were added 50 ml of diethyl ether, 
mixed on a shaker for 4 h, and centrifuged at 2000 
rpm for 5 min. Blood fat was extracted from the su-
pernatant. Fatty acid methyl esters were produced 
modified methods of Kocak et al. (2016). For this 
purpose, 4 ml of 2% methanolic NaOH was added to 
each sample (approximately 50-70 μl blood fat) for 
saponification at 95 °C for 2-3 min. Subsequently, 5 
ml of 14% methanolic BF3 was added, and the sam-
ples were maintained at 95 °C for 5 min. Next, the 
samples were added 2 ml of n-heptane, maintained at 
95 °C for 1 min, added 4 ml of saturated NaCl, and 
centrifuged at 1000 rpm. Later, 1.5 ml-portions of the 
resulting supernatant were transferred into vials and 
analyzed by gas chromatography. 
Fatty acid methyl esters were analyzed by gas 
chromatography (Trace 1300, Thermo Scientific, 
USA) using a flame ionization detector (FID). The 
FID temperature was adjusted to 260 0C. Cyanopro-
pylpolysilphenylene-siloxane (length: 60 m, diam-
eter: 0.25 mm × 0.25 μm, film thickness: 0.25 μm) 
(TR-FAME, Thermo Scientific, USA) was used in the 
column. The continuous flow rate of the carrier gas, 
helium, was set as 1.5 ml/min. The dry airflow rate 
was set as 300 ml/min, and the flow rate of hydrogen 
was programmed as 30 ml/min. The injection vol-
ume was 1 μl and the injection was performed in split 
form. The injector temperature was 250 0C. The oven 
temperature was initially set to 100 0C for 3 min, and 
was increased up to 240 0C at a rate of 4 0C/min. The 
unknown peaks in the chromatogram were identified 
by comparison with the standard FAME Mix (Chem-
Lab, Belgium) of known composition, to determine 
the fatty acids. 
Statitstical Analysis
The values obtained in fatty acid analyses were 
evaluated with Student’s t-test using the Statistical 
Package for Social Sciences (SPSS, version 14.0) 
software.
RESULTS
The fatty acid composition of blood is shown in 
Table 1. Sum and ratios of blood fatty acids are shown 
in Table 2.
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Table 1. Fatty acid composition of blood (Means ± SE)
Fatty acids (%) Groups PControl (n=9) Tumour (n=9)
Capriylic acid 0,013±0,001 0,133±0,071 0,184
Capric acid 0,079±0,002 0,165±0,040 0,075
Undecylic acid 0,012±0,001 0,019±0,004 0,326
Lauric acid 0,062±0,014 0,116±0,019 0,047
Tridecylic acid 0,012±0,001 0,047±0,007 0,001
Myristic acid 0,468±0,051 0,583±0,040 0,089
Myristoleic acid 0,057±0,009 0,086±0,017 0,200
Pentadecylic acid 0,156±0,018 0,106±0,014 0,045
Pentadecanoic acid 0,047±0,018 0,036±0,017 0,669
Palmitic acid 14,892±0,957 15,395±0,845 0,699
Palmitoleic acid 1,732±0,313 1,629±0,211 0,783
Heptadecanoic acid 0,367±0,031 0,284±0,048 0,189
Stearic acid 7,395±0,527 11,269±0,812 0,003
Oleic acid 19,734±1,22 18,711±1,013 0,525
Linoleic acid  ω 6 26,469±1,412 25,260±1,457 0,566
Ɣ- Linolenic acid  ω 6 0,750±0,127 0,490±0,069 0,025
Linolenic acid  ω 3 0,209±0,067 0,102±0,015 0,109
Arachidic acid 0,647±0,103 0,362±0,057 0,022
Paullinic acid 0,266±0,034 0,311±0,071 0,604
Eicosadienoic acid   ω 6 0,364±0,203 0,152±0,041 0,272
Eicosatrienoic acid  ω 6 0,225±0,102 10,443±0,861 <0,001
Eicosatrienoic acid   ω 3 11,980±0,973 0,230±0,043 <0,001
Arachidonic acid  ω 6 0,692±0,410 0,151±0,090 0,173
Eicosapentaenoic acid  ω 3 0,395±0,124 0,371±0,076 0,866
Heneicosanoic acid 0,280±0,046 0,226±0,031 0,337
Erucic acid 12,408±1,034 11,606±0,552 0,480
Docosadienoic acid  ω 6 0,176±0,085 0,338±0,156 0,478
Docosahexaenoic acid  ω 3 0,371±0,050 0,382±0,085 0,917
Lignoceric acid 0,798±0,037 0,710±0,121 0,544
Nervonic acid 0,064±0,009 0,391±0,143 0,059
Significant level was accepted as P<0,05
Table 2. Sum and ratios of blood fatty acids (Means±SE)
Fatty acid (%) Groups PControl (n=9) Tumour (n=9)
ƩSFA 23,892±1,272 29,136±1,042 0,005
ƩMUFA 34,678±1,174 33,053±1,167 0,347
ƩPUFA 41,428±1,235 37,809±1,305 0,066
ƩUFA 76,107±1,272 70,863±1,042 0,005
Ʃ PUFA/ ƩSFA 1,772±0,114 1,320±0,078 0,004
ƩUFA/ ƩSFA 3,254±0,185 2,472±0,124 0,002
Ʃ ω 6 28,471±1,449 36,722±1,298 0,001
Ʃ ω 3 12,748±0,962 0,984±0,146 <0,001
Ʃ ω 6/ Ʃ ω 3 2,344±0,226 42,296±4,166 <0,001
Significant level was accepted as P<0,05
SFA: Saturated fatty acids; MUFA: Monounsaturated fatty acids; PUFA: Polyunsaturated fatty acids
Histopathological Findings
Histopathological examination demonstrated that 
each of the nine mammary masses were malignant tu-
mours. Four of the cases were diagnosed with mixed 
carcinoma (Fig. 1). In these cases, histopathologically, 
the malignant epithelial fusion, observed in the form 
of irregular tubules, was supported by a fibrovascu-
lar stroma. This mass contained sporadic non-atypi-
cal cartilaginous formations and mesenchymal tissue 
composed of benign fusiform myoepithelial cells.
http://epublishing.ekt.gr | e-Publisher: EKT | Downloaded at 23/08/2021 05:31:41 |
J HELLENIC VET MED SOC 2021, 72(2)
ΠΕΚΕ 2021, 72(2)
2930 T. TUZLU, M.K. SARIBAY, E. KOLDAŞ ÜRER, A. M. KÖSE , A. GÖZER, A. YAKAN, Ş. Y. ÖZSOY
Fig.1. Mixed carcinoma
Three of the cases were diagnosed with tubular 
carcinoma (Fig. 2). These malignant tumours con-
tained tubular and gland-like structures. The tubules 
were lined by a single layer or two layers of nuclear 
pleomorphic cells with an eosinophilic cytoplasm and 
hyperchromatic nucleus. The intertubular spaces con-
tained sporadic aggregates of fibroblasts and inflam-
matory cells, including plasma cells, macrophages 
and lymphocytes.
Fig.2. Tubular carcinoma
One case was diagnosed with malignant mesen-
chymal tumour (fibrosarcoma) (Fig. 3).This malig-
nant tumour originated from the interstitial stroma of 
the mammary gland and was characterized by the pro-
liferation of interwoven fusiform cells. The neoplastic 
cells had indistinct cell borders, a small amount of eo-
sinophilic fibrillary cytoplasm, and an oval elongated 
nucleus.
Fig.3. Malignant mesenchymal tumour (fibrosarcoma) 
One case was diagnosed with carcinoma and ma-
lignant myoepithelioma (Fig. 4).The tumour con-
tained both epithelial and myoepithelial components 
of malignant character. The cells, which varied from 
cuboidal to columnar in shape, formed irregular tu-
bules. Furthermore, the interstitium contained atypi-
cal cells with an oval-fusiform vesicular nucleus and 
eosinophilic cytoplasm. These cells were surrounded 
by a small amount of basophilic fibrillary material 
(myxoid matrix), which was also observed within the 
cytoplasm of some of the cells.
Fig.4. Carcinoma and malignant myoepithelioma
DISCUSSION
It has been reported that the serum fatty acid pro-
file of an individual is a reflection of the fatty acid 
composition of his/her diet (Cohen et al., 1993), and 
that the ratio of ω-3 fatty acids to ω-6 fatty acids in 
the serum is an indicator of the level of dietary intake 
of these fatty acids (Yang et al., 2014). Thus, the mea-
surement of serum LA levels is suggested as a reliable 
method of determining the dietary intake level of LA 
(Dougherty et al., 1987). Söderhjelm (1962) reported 
that linoleic acid supplementation caused substantial 
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changes in the level of the fatty acid in the serum in 
dogs. In a study examining the effect of dietary intake 
of fatty acid on serum fatty acid levels, it was shown 
that fatty acid supplementation can be used to change 
serum and cutaneous fatty acid composition of dogs. 
Sunflower (78% 18:2n6) supplementation to Beagle 
puppies increased serum linoleic acid (18:2n6) levels 
after three weeks. In the control group in which no 
supplementation of fatty acid are made, there is no 
significant change in serum fatty acid profile through-
out the study period (12 weeks) (Campbell and Dorn, 
1992). Therefore, it may be inferred that serum lin-
oleic acid levels is a reflection of dietary fatty acid in-
take. In the present study, serum fatty acid levels were 
determined in both healthy female dogs and female 
dogs with mammary tumour (Table1).
In a study carried out in mice, Rose et al. (1995) 
determined that primary tumour growth was delayed 
and lung metastasis was less in animals given feed 
that was supplemented with ω-3 fatty acids(EPA and 
DHA), compared to animals given feed containing 
8% of ω-6 fatty acids (LA). The researchers attributed 
this result to the inhibitory effect ofω-3 fatty acids on 
tumour eicosanoid biosynthesis. 
There is a limitation in our study concerning diet. 
We couldn’t exact amount of diet, preparation or va-
riety of homemade food. However, due to the local 
eating habits, it is possible that dogs had been fed with 
red meats. Alenza et al. (1998) stated that homemade 
meals and high intake of red meat are associated with 
the risk for mammary tumour in female dogs. This 
contrasts with our results. In our study, both groups 
are fed with mainly homemade food. 
Given the impact of diet on the development of 
mammary tumours in humans, diet-related factors 
have been well scrutinized. Multiple factors, including 
among others, advanced age, neutering, undergoing 
ovariohysterectomy after 2-5 years of age, and pro-
gesterone treatment, all increase the risk of mammary 
tumour development (Benavente et al., 2016). Simon 
et al. (2006) has reported that mammary tumour inci-
dence is highest in female dogs aged 8 years and older. 
In the present study, four of these female dogs were 8 
years old, one was 9 years old, and the remaining four 
were aged 10 years or older. Of the female dogs with 
mammary tumour, only two were reported to have 
undergone ovariohysterectomy, and these animals 
had been neutered after the age of five. Similarly, the 
healthy female dogs were also determined to be fed 
mainly on homemade food, and those that were older 
than 5 years of age were sampled for blood. 
It is reported that the most common mammary tu-
mours in female dogs are mixed tumours (67%), and 
adenomas and adenocarcinomas (32%) (Gültiken and 
Vural, 2004). Moulton (1990) suggested that almost 
half of all mammary tumours are of the mixed type, 
and 37% are adenocarcinomas. Furthermore, Fidler 
and Brodey (1967) indicated that of all mammary 
tumours, 50-65% are mixed tumours, 25-40% are 
carcinomas, and the remaining are either hyperpla-
sic structures, adenomas or myoepitheliomas. In the 
present study, all of the mammary masses were con-
firmed to be malignant tumours. Four were diagnosed 
as mixed carcinomas (Fig.1), 3 as tubular carcinomas 
(Fig.2), 1 as fibrosarcoma (Fig.3), and 1 as carcinoma 
and malign myoepithelioma (Fig.4). 
The inhibitory effect of ω-3 fatty acids on mam-
mary tumours is explained by these EFAs supressing 
the generation of arachidonic acid-derived prosta-
noids (prostaglandin E2), which are responsible for 
inflammatory response, cell growth, apoptosis, angio-
genesis and metastasis. It is reported that ω-3 fatty 
acids increase apoptosis and decrease the rate of mito-
sis in the mammary gland. It is also hypothesised that 
ω-3 fatty acids alter membrane stability in tumour 
cells (Habermann et al., 2010). Huerta-Yepezet et al. 
(2016) reported that omega-3 fatty acids show an an-
tiangiogenic effect by inhibiting the synthesis of sev-
eral angiogenic mediators, including vascular endo-
thelial growthfactor (VEGF), platelet-derived growth 
factor (PDGF) and prostaglandin E2 (PGE2). Fabian 
et al. (2015) indicated that, EPA and DHA, which in-
crease with arachidonic acid and belong to the family 
of ω-3 fatty acids, reduce the risk of mammary tu-
mour development by decreasing the level of pro-in-
flammatory lipid derivatives, inhibiting the synthesis 
of nuclear factor-κB-induced cytokines, and reducing 
growth factor receptor signals due to cell membrane 
changes. In the present study, it was determined that 
serum ω-3 fatty acid levels were higher in the healthy 
female dogs, compared to those diagnosed with mam-
mary tumour (p<0.001) (Table2). Besides, omega-6 
level were found higher in female dogs with mamma-
ry tumour. The difference between ω-3 and ω-6 levels 
on mammary tumors was found to be caused mainly 
by Eicosatrienoic acid (Table 2).
Tumours consist of different cell types with stem-
cell character having capability of self-renewal, dif-
ferentiation and high-tumorigenic activity. Also, these 
cells are responsible for lower sensivity to chemother-
apy and radiotherapy. These cells are term as cancer 
stem cells (CSCs) or tumor-initiating cells (TICs) 
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which are a contributing factor in initiation, recur-
rence and metastasis of tumours (Clarke et al., 2006; 
Nguyen et al., 2012). In canine mammary tumours, 
CSCs can be detected by using a sphere-forming as-
say. CSCs derived from canine mammary cancer lines 
are of high tumorigenic activity in immune deficient 
mice. CSCs also have ability to resist to anticancer 
drugs. So, CSCs show stem-cell like features (Mich-
ishita et al., 2011; Pang et al., 2011). In canine mam-
mary adenocarsinoma cell culture study, DHA levels 
in sphere-forming cells (CSCs) were found to be low 
and variable (Michishita et al., 2011). It was stated 
that EPA and DHA inhibit the ability of self-renewal 
and decrease the survival of CSC via apoptosis (Er-
ickson and Hubbard, 2010; Yang et al., 2013).
The main components for the production of eico-
sanoids are AA and EPA which is produced by metab-
olizing omega-6 and omega-3 fatty acids respective-
ly. However AA and EPA, leads to the production of 
eicosanoids which has opposite effects. Typically, AA 
leads to the emergence of eicosanoids that stimulate 
mammary tumors, while EPA causes the emergence 
of eicosanoids which has preventive effects on mam-
mary tumors (Rose, 1997; Cowing and Saker, 2001; 
Gebauer et al., 2005). It has been reported that ω-6 
fatty acids increase the synthesis of AA, and thereby, 
accelerate cell division, supress the immune system, 
and enhance the growth, development and spread of 
tumours (Abou-El-Ela et al., 1989). It is suggested 
that a diet rich in ω-6 fatty acids disrupts the balance 
between cell proliferation and apoptosis in the mam-
mary gland, and induces cell proliferation (Solanas et 
al., 2010). Moreover, it is indicated that eicosanoids 
produced from ω-6 fatty acids are involved in tumour 
angiogenesis, and thereby, facilitate the growth and 
metastasis of tumours (Rose, 1997). In a study car-
ried out in mice (Lasekan et al., 1990), 16 weeks of 
dietary supplementation with safflower oil, known to 
be rich in ω-6,was observed to increase the incidence 
of mammary tumours and 74% of the cases were di-
agnosed with adenocarcinoma. 
Based on the significant decrease they observed in 
the mammary tumour incidence of mice given EPA- 
or DHA-supplemented feed with an ω-3:ω-6 fatty 
acid ratio of 1:1.8, Noguchi et al. (1997) suggested 
that increasing the ω-3:ω-6 ratio of the diet could pro-
vide protection against the development of mammary 
tumours. In another study conducted by Rose et al. 
(1996), dietary ω-3 supplementation was observed to 
inhibit the local recurrence and metastasis of mamma-
ry tumours in mice, the mammary tumours of which 
were surgically excised. Literature reports suggest 
that rather than the level of ω-3, the ratio of ω-3 to 
ω-6 is important in relation to mammary tumour de-
velopment, and a ratio ranging from 1:1 to 1:2 would 
provide protection against the growth and develop-
ment of mammary tumours. In another study, Abou-
El-Ela et al. (1989) demonstrated that food with anω-
3: ω-6 ratio of 1:2 reduced the formation of mammary 
tumours induced by 7-12 dimethylbenzanthracene 
(DMBA). On the other hand, in the opposite situation, 
in the event of an increased ω-6:ω-3 ratio, it is report-
ed that tumour incidence increases due to a decrease 
in the level of DHA among membrane phospholipids 
(Pettersen, 2012). In a research conducted by Yang et 
al. (2014) on 8,331 mammary tumour cases among 
274,135 participants, the association of the ω-3:ω-6 
fatty acid ratio with the risk of mammary tumour de-
velopment was investigated, and it was determined 
that an increase of 1/10 in the ω-3: ω-6 ratio reduced 
mammary tumour risk by 6%. In their study in mice, 
Fabian et al. (2015) ascertained that increasing the to-
tal ω-6:ω-3 ratio in feed to >1 decreased the incidence 
and multiplicity of mammary tumours by 20-35%. 
In the present study, it was determined that the blood 
ω-6:ω-3 ratio was lower in the healthy female dogs, 
compared to those diagnosed with mammary tumour 
(p<0.001) (Table 2). This result supports the correla-
tion suggested for the blood ω-6:ω-3 ratio and mam-
mary tumour incidence in several literature reports 
(Abou-El-Ela et al., 1989;Rose et al., 1996; Noguchi 
et al., 1997; Pettersen, 2012; Yang et al., 2014; Fabian 
et al., 2015).
Mammary tumours generate a high level of ω-6 me-
tabolites, such as prostaglandin E2, which are known 
to place immune functions under risk and induce tu-
mour growth. On the other hand, ω-3 metabolites have 
been shown to prevent tumour growth. Increased levels 
ofω-3 are reported to have a potential anticarcinogenic 
effect exerted through the inhibition of the generation 
ofω-6 metabolites (Simonsen et al., 1998). Simonsen 
et al. (1998) reported that in mammary tumour cell 
cultures, increasing the ratio of ω-3 fatty acids to ω-6 
fatty acids decreased the generation of prostaglandin 
E2 by the tumours cells, and thus, showed a negative 
correlation with mammary tumour development. In 
another study carried out in mice, Sasakiet al. (1998) 
determined that the PGE2 concentration in the tumour 
tissue was significantly lower in the group with a blood 
ω-3: ω-6 ratio of 1.03, compared to the group with an 
ω-3: ω-6 ratio of 0.01. Simopoulos (1991) determined 
thatω-3 fatty acids reduced the metastasis of mamma-
ry tumours to the lungs in mice. The results of Simo-
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nopoulos (1991) agree with our results stating that the 
lower ω-3 fatty acids in tumour groups. 
In an investigation on the impact of diet on mam-
mary tumour development in mice, Wirfalt et al. 
(2002) determined that high dietary intake levels ofω-
6 fatty acids increased the incidence of mammary tu-
mours. Rose et al. (1991) assigned 58 female mice to 
two equal groups, and provided one group with feed 
that was added 23% of maize oil rich in ω-6 fatty ac-
idsand the other group with feed that was added 5% 
of maize oil for a period of 15 weeks. At the end of 
the first week of the study, the researchers injected 
tumour cells into the mammary tissue of the mice, 
and at the end of the study period, the necropsies per-
formed on the animals demonstrated that in the group 
given feed containing 23% of maize oil, 27 of the ani-
mals had developed tumours, whilst in the group giv-
en feed containing 5% of maize oil, 21 of the animals 
had developed tumours. Furthermore, in the group fed 
on a high-oil diet, out of the 27 animals with mamma-
ry tumour, 18 presented with lung metastasis, whilst 
in the group fed on a low-oil diet, out of the 21 ani-
mals with mammary tumour, 8 presented with lung 
metastasis. In result, the researchers determined that 
the incidence of mammary tumours was high in the 
mice fed on a diet rich in ω-6 fatty acids, and thereby, 
concluded that this type of a diet could also increase 
lung metastasis. In another study carried out in mice, 
Rose et al. (1995) determined that primary tumour 
growth was delayed and lung metastasis was less in 
animals given feed that was supplemented with ω-3 
fatty acids(EPA and DHA), compared to animals giv-
en feed containing 8% of ω-6 fatty acids (LA). The re-
searchers attributed this result to the inhibitory effect 
ofω-3 fatty acids on tumour eicosanoid biosynthesis.
Sonnenschein et al. (1991) showed that high-fat 
diet had protective feature on the mammary tumour 
risk in dogs. But this study have some shortcomings, 
as no detailed information on which type of fatty acid 
are involved in the diet, are presented due to the scarce 
data about dog food preparations. Costa-Santos et al. 
(2019) reported that a relationship between dyslip-
idemia and tumor aggressiveness. Dyslipidemia is a 
substantial factor in the tumour formation (Aravani et 
al., 2018). Higher triglyceride, VLDL, albumin, glob-
ulin and lactate levels were observed in the aggres-
sive carcinomas in overweight/obese dogs. Fish-oil 
supplementation didn’t change the abovementioned 
parameters, but glucose, total protein, globulin lev-
els increased, leading to alter metabolic parameters 
in cancer patients (Costa-Santos et al., 2019). In this 
study, the detection of higher blood ω-6 levels (p 
<0.001) in female dogs with mammary tumors and 
higher serum ω-3 levels (p <0.001) in healthy female 
dogs support the opinion that fatty acid levels may be 
associated with mammary tumor risk.
CONCLUSIONS
In result, ω-3 was determined at higher levels in 
the blood of the healthy female dogs whereas ω-6 was 
detected at higher levels in the female dogs diagnosed 
with mammary tumour.This suggest that omega fat-
ty acids may be an important factor in the biological 
mechanism of canine mammary tumour development.
We consider that the obvious differences between blood 
level ofω-3 and ω-6 might be caused by Eicosatrienoic 
acids. Further research should be done to understand 
the exact mechanism of how ω-3 and ω-6 contribute to 
development of female dog mammary tumours. 
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